Sam L. Barker, Director at LEXICON PHARMACEUTICALS, INC./DE (LXRX), bought 40,000 shares at $1.96 ($79K) on 2008-04-18, disclosed to the SEC on 2008-04-22.
Open-market purchase of $79k LXRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.93 | 5,000 | $10K | 12.3% |
| 2 | $1.95 | 11,025 | $21K | 27.4% |
| 3 | $1.96 | 3,975 | $8K | 9.9% |
| 4 | $1.97 | 1,100 | $2K | 2.8% |
| 5 | $1.98 | 16,700 | $33K | 42.1% |
| 6 | $1.99 | 300 |
| $597 |
| 0.8% |
| 7 | $2.00 | 1,900 | $4K | 4.8% |
| Total | $1.96 avg | 40,000 | $79K | 100% |
| Filing → |
| LXRX | BUY | 2019-08-02 | $28K | — | Filing → |
| LXRX | BUY | 2017-09-18 | $13K | — | Filing → |
| CYCC | BUY | 2014-11-20 | $9K | — | Filing → |